292 related articles for article (PubMed ID: 28695297)
1. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
Facchetti F; Pileri SA; Lorenzi L; Tabanelli V; Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Rosenwald A; Wotherspoon A; Fend F
Virchows Arch; 2017 Oct; 471(4):467-489. PubMed ID: 28695297
[TBL] [Abstract][Full Text] [Related]
2. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
[TBL] [Abstract][Full Text] [Related]
3. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
4. Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.
Tzankov A; Kremer M; Leguit R; Orazi A; van der Walt J; Gianelli U; Hebeda KM
Ann Hematol; 2018 Nov; 97(11):2117-2128. PubMed ID: 30084011
[TBL] [Abstract][Full Text] [Related]
5. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
6. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
[TBL] [Abstract][Full Text] [Related]
7. Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.
Okada K; Takahara T; Suzuki Y; Kohno K; Sakakibara A; Satou A; Takahashi E; Nakamura S
Pathol Int; 2021 Jan; 71(1):24-32. PubMed ID: 33238073
[TBL] [Abstract][Full Text] [Related]
8. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.
Pileri SA; Grogan TM; Harris NL; Banks P; Campo E; Chan JK; Favera RD; Delsol G; De Wolf-Peeters C; Falini B; Gascoyne RD; Gaulard P; Gatter KC; Isaacson PG; Jaffe ES; Kluin P; Knowles DM; Mason DY; Mori S; Müller-Hermelink HK; Piris MA; Ralfkiaer E; Stein H; Su IJ; Warnke RA; Weiss LM
Histopathology; 2002 Jul; 41(1):1-29. PubMed ID: 12121233
[TBL] [Abstract][Full Text] [Related]
9. Histiocytic and Dendritic Cell Neoplasms.
Pan Z; Xu ML
Surg Pathol Clin; 2019 Sep; 12(3):805-829. PubMed ID: 31352989
[TBL] [Abstract][Full Text] [Related]
10. Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
Go H; Jeon YK; Huh J; Choi SJ; Choi YD; Cha HJ; Kim HJ; Park G; Min S; Kim JE
Histopathology; 2014 Aug; 65(2):261-72. PubMed ID: 24720374
[TBL] [Abstract][Full Text] [Related]
11. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
12. Histiocytic sarcoma with interdigitating dendritic cell differentiation: a case report with fine needle aspiration cytology and review of literature.
Yang GC; Besanceney CE; Tam W
Diagn Cytopathol; 2010 May; 38(5):351-6. PubMed ID: 19845032
[TBL] [Abstract][Full Text] [Related]
13. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.
Dorfman DM; Hornick JL; Shahsafaei A; Freeman GJ
Hum Pathol; 2010 Oct; 41(10):1486-94. PubMed ID: 20656318
[TBL] [Abstract][Full Text] [Related]
14. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
Affolter VK; Moore PF
Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
[TBL] [Abstract][Full Text] [Related]
15. Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin.
Satpathy AT; Brown RA; Gomulia E; Briseño CG; Mumbach MR; Pan Z; Murphy KM; Natkunam Y; Chang HY; Kim J
Mod Pathol; 2018 Sep; 31(9):1479-1486. PubMed ID: 29743654
[TBL] [Abstract][Full Text] [Related]
16. Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders.
Xu J; Sun HH; Fletcher CD; Hornick JL; Morgan EA; Freeman GJ; Hodi FS; Pinkus GS; Rodig SJ
Am J Surg Pathol; 2016 Apr; 40(4):443-53. PubMed ID: 26752545
[TBL] [Abstract][Full Text] [Related]
17. A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma--a diagnostic pitfall.
Johnson RL; Boisot S; Ball ED; Wang HY
Int J Clin Exp Pathol; 2014; 7(1):378-85. PubMed ID: 24427360
[TBL] [Abstract][Full Text] [Related]
18. Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016.
Král Z; Adam Z; Ježová M; Pour L; Krejčí M
Vnitr Lek; 2020; 66(6):19-27. PubMed ID: 33380149
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.
Dalia S; Jaglal M; Chervenick P; Cualing H; Sokol L
Cancers (Basel); 2014 Nov; 6(4):2275-95. PubMed ID: 25405526
[TBL] [Abstract][Full Text] [Related]
20. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.
Favara BE; Feller AC; Pauli M; Jaffe ES; Weiss LM; Arico M; Bucsky P; Egeler RM; Elinder G; Gadner H; Gresik M; Henter JI; Imashuku S; Janka-Schaub G; Jaffe R; Ladisch S; Nezelof C; Pritchard J
Med Pediatr Oncol; 1997 Sep; 29(3):157-66. PubMed ID: 9212839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]